Abel Hall LLC’s MetLife MET Stock Holding History

Abel Hall LLC’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,475	Closed	-$353K	–	912
2025 Q4	$353K	Buy	+4,475	New	+$354K	0.08%	266

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Abel Hall LLC's MET Position: Q1 2026 in Review

Abel Hall LLC sold out of MetLife (MET) in Q1 2026, closing a stake of 4,475 shares — an estimated $353K sold.

Abel Hall LLC first reported a position in MET in Q4 2025 and held it in 1 quarter. The position peaked at $353K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Abel Hall LLC reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 4,475 MetLife shares in Q1 2026, an estimated $353K.
Abel Hall LLC first reported a position in MetLife in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's MetLife position peaked at $353K in Q4 2025.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.